Publisert 25.06.2019

Annual Report 2018

Regenics post a positive 2018 result of 1.72 mill NOK. 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.